iShares NASDAQ Biotechnology Index (ETF)  

(Public, NASDAQ:IBB)   Watch this stock  
Find more results for IBB
-0.40 (-0.36%)
Feb 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 109.88 - 111.54
52 week 94.20 - 119.30
Open 110.74
Vol / Avg. 0.00/3.33M
Mkt cap 9.67B
P/E 3.65
Div/yield     -/0.29
EPS 30.28
Shares 87.85M
Beta 1.37
Inst. own 62%

Key stats and ratios

Q1 (Mar '15) 2015
Net profit margin 17085.68% 7595.88%
Operating margin -78.14% 5.46%
EBITD margin - 5.46%
Return on average assets 39.51% 29.61%
Return on average equity 45.47% 34.18%
CDP Score - -


United States - Map
+1-415-5972000 (Phone)
+1-415-6185014 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Officers and directors

George G. C. Parker Ph.D. Independent Chairman of the Board of Trustees
Age: 78
Bio & Compensation  - Reuters
Michael Arthur Latham President, Trustee
Age: 51
Bio & Compensation  - Reuters
Jack Gee Chief Financial Officer, Treasurer
Age: 57
Bio & Compensation  - Reuters
Geoffrey D. Flynn Chief Operating Officer, Executive Vice President
Bio & Compensation  - Reuters
Amy Schioldager Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Ira P. Shapiro Vice President, Chief Legal Officer
Age: 52
Bio & Compensation  - Reuters
Matt Tucker Vice President
Bio & Compensation  - Reuters
Eilleen M. Clavere Secretary
Age: 61
Bio & Compensation  - Reuters
Cecilia H. Herbert Independent Trustee
Age: 68
Bio & Compensation  - Reuters
Charles A. Hurty Independent Trustee
Age: 73
Bio & Compensation  - Reuters